These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 380967)

  • 1. [Theoretical aspects of the quantitative study of the chemical structure-biological action relationship].
    Danchev D; Staneva D; Mikhaĭlova D; Nacheva R
    Eksp Med Morfol; 1979; 18(2):61-8. PubMed ID: 380967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiocochemical, quantum chemical, and other theoretical techniques for the understanding of the pharmacologic action of drugs that affect the central nervous system: psychotropic drugs, narcotics, and narcotic antagonists and anesthetics.
    Kaufman JJ
    Cancer Chemother Rep 2; 1974 Dec; 4(4):49-50. PubMed ID: 4447934
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantum chemical and other theoretical techniques for the understanding of the psychoactive action of the phenothiazines.
    Kaufman JJ; Kerman E
    Adv Biochem Psychopharmacol; 1974; 9(0):55-75. PubMed ID: 4836201
    [No Abstract]   [Full Text] [Related]  

  • 4. Recognition and activation mechanisms on the LSD/serotonin receptor: the molecular basis of structure activity relationships.
    Weinstein H; Green JP; Osman R; Edwards WD
    NIDA Res Monogr; 1978; (22):333-58. PubMed ID: 101884
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of dipole moment as a parameter in drug-receptor interaction and quantitative structure-activity relationship studies.
    Lien EJ; Guo ZR; Li RL; Su CT
    J Pharm Sci; 1982 Jun; 71(6):641-55. PubMed ID: 7097526
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent physiochemical and quantum chemical studies on drugs of abuse and relevant biomolecules.
    Kaufman JJ
    NIDA Res Monogr; 1978; (22):250-77. PubMed ID: 30909
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pressing problems of pharmacokinetics].
    Lakin KM; Krylov IuF; Gor'kov VA
    Farmakol Toksikol; 1980; 43(1):5-16. PubMed ID: 6991282
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug interaction].
    Kukes VG; Rudakov AG
    Klin Med (Mosk); 1984 Jun; 62(6):9-16. PubMed ID: 6471806
    [No Abstract]   [Full Text] [Related]  

  • 9. Commentary: The receptor concept in evolution.
    Ariëns EJ; Beld AJ
    Biochem Pharmacol; 1977 May; 26(10):913-8. PubMed ID: 324474
    [No Abstract]   [Full Text] [Related]  

  • 10. An extended isolated molecule method and its applications to the design of new drugs: general aspects.
    Simas AM; Bruns RE; Brown RE
    NIDA Res Monogr; 1978; (22):317-32. PubMed ID: 101883
    [No Abstract]   [Full Text] [Related]  

  • 11. Structure--activity relationships of eseroline and morphine: ab initio quantum-chemical study of the electrostatic potential and of the interaction energy with water.
    Agresti A; Buffoni F; Kaufman JJ; Petrongolo C
    Mol Pharmacol; 1980 Nov; 18(3):461-7. PubMed ID: 7464812
    [No Abstract]   [Full Text] [Related]  

  • 12. Theoretical prediction of drug-receptor interactions.
    Frecer V
    Drug Metabol Drug Interact; 2011; 26(3):91-104. PubMed ID: 21980962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Theoretical investigations of interactions between drugs and models of receptor sites, 3: induced fit interactions of verapamil derivatives].
    Höltje HD; Baranowski P
    Arch Pharm (Weinheim); 1983; 316(2):154-60. PubMed ID: 6847345
    [No Abstract]   [Full Text] [Related]  

  • 14. A theoretical study of receptor site models for trimethylammonium group interaction.
    Kier LB; Aldrich HS
    J Theor Biol; 1974 Aug; 46(2):529-41. PubMed ID: 4419765
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacomolecules-protein bioreceptors interactions.
    Radouco-Thomas C; Garcin F; Radouco-Thomas S; Singh P; Nosal G; Huot J; Wang YK
    Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):231-48. PubMed ID: 5148883
    [No Abstract]   [Full Text] [Related]  

  • 16. [Practical problems of pharmacodynamics].
    Berkhin EB
    Klin Med (Mosk); 1986 Feb; 64(2):146-52. PubMed ID: 3702293
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantum chemical analysis of structure-activity relationships in nonsteroidal anti-inflammatory drugs.
    Mehler EL; Habicht J; Brune K
    Mol Pharmacol; 1982 Nov; 22(3):525-8. PubMed ID: 7155122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying biological activity in chemical terms: a pharmacology primer to describe drug effect.
    Kenakin T
    ACS Chem Biol; 2009 Apr; 4(4):249-60. PubMed ID: 19193052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current problems in drug research. I. Determination of the quantitative structure-activity relationships of biosubstances: theoretical principles, accomplishments, assumptions and present state].
    Franke R; Oehme P
    Pharmazie; 1973 Aug; 28(8):489-508. PubMed ID: 4131698
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chemistry, biochemistry and clinical pharmacology of digitalis glycosides. An overview].
    Dwenger A
    Arzneimittelforschung; 1973 Oct; 23(10):1439-46. PubMed ID: 4273089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.